Compounds > gliclazide

gliclazide and quercetin

gliclazide has been researched along with quercetin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Devínsky, F; Furtmüller, PG; Kameníková, M; Klacsová, M; Lopez-Guzman, A; Mučaji, P; Nagy, M; Toca-Herrera, JL; Vitkovská, A1
Abdelkader, NF; Badawi, MA; Eitah, HE; Gamaleldin, AA; Kenawy, SA; Maklad, YA1
Nishida, S; Satoh, H1

Other Studies

5 other study(ies) available for gliclazide and quercetin

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Influence of quercetin on the interaction of gliclazide with human serum albumin - spectroscopic and docking approaches.
    Luminescence : the journal of biological and chemical luminescence, 2017, Volume: 32, Issue:7

    Topics: Binding, Competitive; Circular Dichroism; Drug Interactions; Gliclazide; Molecular Docking Simulation; Protein Conformation; Quercetin; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared

2017
New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
    Life sciences, 2020, Apr-15, Volume: 247

    Topics: Animals; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Gliclazide; Glutathione; Hypoglycemic Agents; Inflammation; Insulin; Islets of Langerhans; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Pancreas; Quercetin; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha

2020
Role of gap junction involved with endothelium-derived hyperpolarizing factor for the quercetin-induced vasodilatation in rat mesenteric artery.
    Life sciences, 2013, Apr-19, Volume: 92, Issue:13

    Topics: Animals; Antioxidants; Biological Factors; Gap Junctions; Glycyrrhetinic Acid; Indomethacin; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Quercetin; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2013